Search the Newsreel

Enovix Corp (ENVX) (Q2 2026) Earnings Call Highlights: Smart Eyewear Ramp and Drone Pipeline Surge

Enovix Corp (ENVX) reported a 21% year-over-year revenue increase to $9 million in Q2 2026, marking its fifth consecutive quarter of growth, driven by a significant ramp-up in smart eyewear battery shipments and a surge in its drone and defense pipeline to $180 million. …

Lenovo’s AI Revenue Reaches $9.3B, 35% of Q1 Sales

Lenovo Group ADR GAAP EPS of -$5.04, revenue of $26.94B beats by $4.5B

* Lenovo Group ADR press release [https://seekingalpha.com/pr/20617682-lenovo-group-q1-financial-results-2026-27] (LNVGY [https://seekingalpha.com/symbol/LNVGY]): Q1 GAAP EPS of -$5.04. * Revenue of $26.94B (+43.1% Y/Y) beats by $4.5B. * Adjusted net income was up 176% year-on-year to US$1.1 billion, surpassing the US$1 billion milestone for the first time ever, …

China's Lenovo posts 43% jump in Q1 revenue, riding AI infrastructure boom

By Laurie Chen BANGALORE/BEIJING, Aug 13 (Reuters) - China's Lenovo Group reported a 43% jump in quarterly revenue on Thursday, beating forecasts to drive shares up as much as 22%, as the world's largest computer maker rides an AI hardware boom and benefits ‌from …

Lenovo Group: Q1 Financial Results 2026/27

Lenovo delivers strongest quarter in Group history: Hybrid AI strategy powers growth momentum HONG KONG, August 13, 2026--(BUSINESS WIRE)--Lenovo GroupLimited (HKSE: 992) (ADR: LNVGY), together with its subsidiaries ('the Group'), today reported first quarter results for fiscal year 2026/27, marking the highest quarterly revenue …

ENVX Stock Falls Overnight Despite Q2 Beat: Retail Bulls Shrug It Off As CEO Backs Smartphone, Wearables And Defense Demand

Enovix expects Q3 revenue of $9M-$10M as smart eyewear deliveries target ~19,000 packs

Earnings Call Insights: Enovix Corporation (ENVX) Q2 2026 MANAGEMENT VIEW * “The second quarter showed momentum across all 3 of our primary target markets,” and in smartphones “our lead customer confirmed that our cells passed more than 1,000 cycles on the 0.2C discharge cycle …

RenovoRx earnings beat by $0.02, revenue topped estimates

Cenovus Energy Inc (CVE) Stock Forecasts

Argus has raised its target price for Cenovus Energy Inc (CVE) to $33.00, citing the company's focus on creating value through its oil sands assets. Cenovus Energy Inc is described as an integrated oil company. The current price for CVE is $29.89.

Enovix Corporation stock Analysis: Daily and Intraday Momentum Insight

Enovix Corporation (ENVX) stock closed at $4.73, retreating from an intraday high, with its daily chart remaining in a downtrend despite some short-term bounce signals. While daily momentum indicators suggest a pause, not a reversal, hourly charts indicate that the bounce is losing conviction …

RenovoRx, Inc. (RNXT) Reports Q2 Loss, Beats Revenue Estimates

RenovoRx, Inc. (RNXT) reported a Q2 loss of $0.05 per share, surpassing the Zacks Consensus Estimate of a $0.08 loss and an improvement from last year's $0.08 loss. The company also exceeded revenue estimates, posting $0.91 million against an expected $0.73 million. Despite outperforming …

Earnings call transcript: Enovix beats Q2 2026 estimates as shares fall after hours

Enovix (ENVX) reported a smaller-than-expected Q2 2026 loss and higher revenue, yet its shares declined after hours due to investor concerns over near-term margin pressure. The company highlighted progress in smartphone qualification, smart eyewear production, and a growing defense pipeline. Despite beating estimates, the …

RenovoRx Reports Record Second Quarter 2026 Results, Driven by Accelerating Commercial Adoption and 61% Sequential Quarterly Revenue Growth

RenovoRx announced record financial results for the second quarter of 2026, with revenue reaching $909,000, marking a 61% sequential quarterly increase and a 115% year-over-year increase. The company raised its 2026 annual revenue guidance to a range of $3.75 million to $4.25 million, driven …

RenovoRx (NASDAQ:RNXT) Posts Earnings Results, Beats Estimates By $0.02 EPS

RenovoRx (NASDAQ:RNXT) reported a narrower-than-expected quarterly loss of $0.05 per share, surpassing consensus estimates by $0.02. The company also saw significant revenue growth, climbing 61% sequentially and 115% year-over-year to $909,000, leading management to raise its 2026 revenue guidance. Despite this progress, RenovoRx remains …

Earnings call transcript: RenovoRx posts Q2 2026 beat, lifts guidance

RenovoRx announced a strong Q2 2026 performance, exceeding Wall Street expectations with higher-than-forecasted revenue of $909,000 and a smaller loss of 6 cents per share. The medical device company raised its full-year 2026 revenue guidance to $3.75 million to $4.25 million, citing record quarterly …

Enovix Corporation (ENVX) Reports Q2 Loss, Tops Revenue Estimates

Enovix Corporation (ENVX) reported a Q2 loss of $0.13 per share, exceeding the Zacks Consensus Estimate of a $0.14 loss, and surpassed revenue estimates with $9.02 million. Despite consistently beating EPS estimates over the last four quarters, the company's shares have declined 33.9% year-to-date. …

Earnings Flash (ENVX) Enovix Posts Q2 Revenue $9M, vs. FactSet Est of $8.4M

Enovix Corporation reported Q2 revenue of $9 million, surpassing FactSet's estimate of $8.4 million. The company also released its Q3 outlook, expecting a non-GAAP net loss per share between $0.17 and $0.13 and revenue ranging from $9 million to $10 million. Enovix specializes in …

Enovix (NASDAQ:ENVX) Issues Quarterly Earnings Results

Enovix Corporation (NASDAQ: ENVX) grows revenue but absorbs higher 2026 losses

Enovix Corporation reported increased revenue for both the fiscal quarter and year-to-date periods ending July 5, 2026, primarily driven by sales to defense and industrial customers. Despite revenue growth, the company experienced wider net losses for the year-to-date, reaching $81.3 million, largely due to …

Enovix Corp 2Q 2026: Revenue $9.02M, EPS ($0.2) — 10-Q Summary

Enovix Corp (ENVX) reported its second-quarter 2026 results, showing a revenue increase to $9.02M, up 20.8% year-over-year. Despite the revenue growth, the company posted a net loss of ($43.06M) and a diluted loss per share of ($0.2). Business highlights include the launch of the …

Cenovus Energy Inc. stock rises Wednesday, outperforms market

Cenovus Energy Inc. (CVE) shares rose 1.32% to C$42.11 on Wednesday, outperforming the S&P/TSX Composite Index, which increased by 0.51%. The stock closed 4.6% below its 52-week high of C$44.13. This performance occurred during a generally favorable trading session for the Canadian market.

RenovoRx Inc (RNXT) (Q2 2026) Earnings Call Highlights: Record Revenue and Strategic Expansion ...

RenovoRx Inc (RNXT) reported record Q2 2026 revenue of $909,000, a 61% sequential and 115% year-over-year increase, driven by an expanded commercial presence in cancer centers. The company also announced full enrollment for its Phase 3 TIGERPAC trial, with top-line data expected in late …

Here's How Much $100 Invested In Cenovus Energy 5 Years Ago Would Be Worth Today

This article analyzes the performance of Cenovus Energy (NYSE: CVE) stock over the past five years. An investment of $100 in CVE five years ago would now be worth $382.95, reflecting an average annual return of 31.17%. The article highlights the significant impact of …

Enovix Stock Leads 3 Financially Fit Penny Stocks Worth A Closer Look

This article identifies three "financially fit" penny stocks—Enovix (ENVX), Clover Health Investments (CLOV), and Hyliion Holdings (HYLN)—that exhibit stronger balance sheets and financial health compared to many early-stage peers. Enovix focuses on advanced lithium-ion batteries, Clover Health offers Medicare Advantage plans and healthcare software, …

Enova Mining Progresses Resource Delineation Drilling at Brazil's Naked Hill IAC REE Project

Enova Mining Advances Resource Delineation Drilling at Naked Hill IAC REE Project in Brazil

Enovix Corp (ENVX) CEO withholds 4,300 shares to cover RSU tax liability

Enovix Corp's President and CEO, Rajendra K. Talluri, reported a Form 4 transaction where 4,300 shares of common stock were withheld to cover tax liabilities stemming from the vesting of restricted stock units (RSUs). This transaction, valued at $4.70 per share, was a tax-related …

Enovix (ENVX) CLO withholds 936 shares for taxes, retains 583,535-share stake

Enovix Corp's Chief Legal Officer, Arthi Chakravarthy, reported the withholding of 936 common shares valued at $4.70 per share to cover tax obligations from vested restricted stock units (RSUs). Following this transaction, Chakravarthy directly retains 583,535 shares of Enovix common stock. This total includes …

Lenovo (SEHK:992) Stock Looks Reasonable By Sector Yet Stretched On Earnings

Find winning stocks in any market cycle. Join 7 million investors using Simply Wall St's investing ideas for FREE. Lenovo Group's share price has surged over the past few years, yet its current valuation checks point to a stock that screens as overvalued on …

Operating margin % of Enova International Inc – HAM:27E

This article displays the operating margin percentage for Enova International Inc (HAM:27E) on TradingView. It provides a brief overview of the company's financial data on the Hamburg Stock Exchange. The content is primarily a data placeholder within a financial platform's interface.

Revenue per share of Enova International Inc – HAM:27E

The article focuses on the "Revenue per share" metric for Enova International Inc (HAM:27E) on the Hamburg Stock Exchange. It appears to be a financial data page from TradingView, providing an overview of the company's financial performance.

Can Enovis (ENOV) Narrowing Losses Without Strong Sales Growth Sustain Its Long-Term Strategy?

Enovis Corporation (ENOV) reported Q2 2026 sales of US$582.78 million, a modest increase year-over-year, and significantly reduced its net loss to US$1.19 million from US$36.74 million. The company reaffirmed its 2026 revenue guidance of US$2.31 billion to US$2.37 billion, indicating management's confidence despite only …

RenovoRx completes enrollment in phase III pancreatic cancer trial

RenovoRx (NASDAQ:RNXT) has completed enrollment in its Phase III TIGeR-PaC trial for locally advanced pancreatic cancer, with patient enrollment closing on August 7th. The company anticipates trial completion by the first half of 2027, with initial topline data expected in the second half of …

Lenovo's Overbought Rally Meets Its Moment of Truth as Earnings Land This Week

RenovoRx pancreatic cancer trial closes enrollment; 78 deaths occurred

RenovoRx announced the full enrollment of its Phase III

EXCLUSIVE: Renovorx Advances Its Targeted Pancreatic Cancer Therapy, Pivotal Data Expected in 2027

RenovoRx, Inc. (NASDAQ: RNXT) has completed patient enrollment for its Phase 3 TIGeR-PaC study for locally advanced pancreatic cancer (LAPC), utilizing its RenovoCath targeted drug delivery platform. The study, which compares intra-arterial gemcitabine (IAG) against standard systemic chemotherapy, is expected to conclude in the …